AAAAAA

   
Results: 1-25 | 26-35
Results: 1-25/35
10 YEARS NEUROBLASTOMA SCREENING IN EUROPE - PRELIMINARY-RESULTS OF ACLINICAL AND BIOLOGICAL REVIEW FROM THE STUDY-GROUP FOR EVALUATION OFNEUROBLASTOMA SCREENING IN EUROPE (SENSE)
Authors: ERTTMANN R TAFESE T BERTHOLD F KERBL R MANN J PARKER L SCHILLING F AMBROS P CHRISTIANSEN H FAVROT M KABISCH H HERO B PHILIP T
Citation: R. Erttmann et al., 10 YEARS NEUROBLASTOMA SCREENING IN EUROPE - PRELIMINARY-RESULTS OF ACLINICAL AND BIOLOGICAL REVIEW FROM THE STUDY-GROUP FOR EVALUATION OFNEUROBLASTOMA SCREENING IN EUROPE (SENSE), European journal of cancer, 34(9), 1998, pp. 1391-1397
HIGHLY EFFICIENT AND NONTOXIC DNA ISOLATION FROM VERY OLD BONE-MARROWSMEARS
Authors: ANDEREGG B SCHLUTER S KABISCH H
Citation: B. Anderegg et al., HIGHLY EFFICIENT AND NONTOXIC DNA ISOLATION FROM VERY OLD BONE-MARROWSMEARS, Leukemia, 12(5), 1998, pp. 774-775
BUSULFAN, CYCLOPHOSPHAMIDE AND ETOPOSIDE AS HIGH-DOSE CONDITIONING THERAPY IN PATIENTS WITH MALIGNANT-LYMPHOMA AND PRIOR DOSE-LIMITING RADIATION-THERAPY
Authors: KROGER N HOFFKNECHT M HANEL M KRUGER W ZELLER W STOCKSCHLADER M DEWIT M WEH HJ KABISCH H ERTTMANN R ZANDER AR
Citation: N. Kroger et al., BUSULFAN, CYCLOPHOSPHAMIDE AND ETOPOSIDE AS HIGH-DOSE CONDITIONING THERAPY IN PATIENTS WITH MALIGNANT-LYMPHOMA AND PRIOR DOSE-LIMITING RADIATION-THERAPY, Bone marrow transplantation, 21(12), 1998, pp. 1171-1175
LIPOSOMAL AMPHOTERICIN-B FOR PATIENTS UNDERGOING MARROW OR BLOOD STEM-CELL TRANSPLANTATION
Authors: KRUGER WH RUSSMANN BC KROGER N EKOPF N FUCHS N RENGES H BIELING P SOBOTTKA I ERTTMANN R KABISCH H ZANDER AR
Citation: Wh. Kruger et al., LIPOSOMAL AMPHOTERICIN-B FOR PATIENTS UNDERGOING MARROW OR BLOOD STEM-CELL TRANSPLANTATION, Bone marrow transplantation, 21, 1998, pp. 531-531
HIGH-DOSE CHEMOTHERAPY WITH BUSULFAN, CYCLOPHOSPHAMIDE, AND ETOPOSIDEAS CONDITIONING REGIMEN FOR ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR PATIENTS WITH ACUTE MYELOID-LEUKEMIA IN FIRST COMPLETE REMISSION
Authors: ZANDER AR BERGER C KROGER N STOCKSCHLADER M KRUGER W HORSTMANN M GRIMM J ZELLER W KABISCH H ERTTMANN R SCHONROCK P KUSE R BRAUMANN D ILLIGER HJ FIEDLER W DEWITT M HOSSFELD KD WEH HJ
Citation: Ar. Zander et al., HIGH-DOSE CHEMOTHERAPY WITH BUSULFAN, CYCLOPHOSPHAMIDE, AND ETOPOSIDEAS CONDITIONING REGIMEN FOR ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR PATIENTS WITH ACUTE MYELOID-LEUKEMIA IN FIRST COMPLETE REMISSION, Clinical cancer research, 3(12), 1997, pp. 2671-2675
IN-VITRO CULTURE STUDIES OF CHILDHOOD MYELODYSPLASTIC SYNDROME - ESTABLISHMENT OF THE CELL-LINE MUTZ-1
Authors: STEUBE KG GIGNAC SM HU ZB TEEPE D HARMS D KABISCH H GAEDICKE G HANSENHAGGE T MACLEOD RAF QUENTMEIER H DREXLER HG
Citation: Kg. Steube et al., IN-VITRO CULTURE STUDIES OF CHILDHOOD MYELODYSPLASTIC SYNDROME - ESTABLISHMENT OF THE CELL-LINE MUTZ-1, Leukemia & lymphoma, 25(3-4), 1997, pp. 345
ALLOGENEIC TRANSPLANTATION WITH CD34(-SELECTED CELLS())
Authors: STOCKSCHLADER M HASSAN HT ZELLER W KRUGER W CLAUSEN J LOLIGER C DIECK AT KROGER N LINK H KABISCH H HOSSFELD DK ZANDER A
Citation: M. Stockschlader et al., ALLOGENEIC TRANSPLANTATION WITH CD34(-SELECTED CELLS()), Leukemia & lymphoma, 25(1-2), 1997, pp. 145-151
EFFECTS OF ANTI-TAL-1 OLIGODEOXYNUCLEOTIDES IN T-ALL CELL-LINES
Authors: ANDEREGG B HORSTMANN M KABISCH H
Citation: B. Anderegg et al., EFFECTS OF ANTI-TAL-1 OLIGODEOXYNUCLEOTIDES IN T-ALL CELL-LINES, Cancer gene therapy, 4(2), 1997, pp. 84-90
TRANSCRIPTION OF TAL-1, A PUTATIVE ONCOGENE PLAYING AN IMPORTANT ROLEIN CHILDHOOD T-ALL, CAN BE SHOWN IN NORMAL PERIPHERAL-BLOOD CELLS BY A HIGHLY SENSITIVE RT-PCR ASSAY
Authors: ANDEREGG B HORSTMANN M ERNST M KABISCH H
Citation: B. Anderegg et al., TRANSCRIPTION OF TAL-1, A PUTATIVE ONCOGENE PLAYING AN IMPORTANT ROLEIN CHILDHOOD T-ALL, CAN BE SHOWN IN NORMAL PERIPHERAL-BLOOD CELLS BY A HIGHLY SENSITIVE RT-PCR ASSAY, Pediatric hematology and oncology, 14(4), 1997, pp. 349-358
MATCHED UNRELATED DONOR TRANSPLANT WITH A FIVEFOLD GVH PREVENTION - SINGLE-CENTER EXPERIENCE
Authors: ZANDER AR ZABELNIA T KROGER N KRUGER W STOCKSCHLADER M GRIMM J KABISCH H ERTTMANN R
Citation: Ar. Zander et al., MATCHED UNRELATED DONOR TRANSPLANT WITH A FIVEFOLD GVH PREVENTION - SINGLE-CENTER EXPERIENCE, Experimental hematology, 25(8), 1997, pp. 324-324
CONDITIONING WITH BUSULFAN, ETOPOSIDE (VP16) AND CYCLOPHOSPHAMIDE IN AML IN FIRST REMISSION
Authors: ZANDER AR BERGER C KROGER N SCHONROCK P KRUGER W STOCKSCHLADER M BIELING P KABISCH H FIEDLER W DEWIT M HUTTMANN A GRIMM J ERTTMANN R KUSE R
Citation: Ar. Zander et al., CONDITIONING WITH BUSULFAN, ETOPOSIDE (VP16) AND CYCLOPHOSPHAMIDE IN AML IN FIRST REMISSION, Experimental hematology, 25(8), 1997, pp. 480-480
LONG-TERM FOLLOW-UP OF LEUKEMIA PATIENTS AFTER RELATED CRYOPRESERVED ALLOGENEIC BONE-MARROW TRANSPLANTATION
Authors: STOCKSCHLADER M HASSAN HT KROG C KRUGER W LOLIGER C HORSTMAN M ALTNODER M CLAUSEN J GRIMM J KABISCH H ZANDER A
Citation: M. Stockschlader et al., LONG-TERM FOLLOW-UP OF LEUKEMIA PATIENTS AFTER RELATED CRYOPRESERVED ALLOGENEIC BONE-MARROW TRANSPLANTATION, British Journal of Haematology, 96(2), 1997, pp. 382-386
FREQUENT REDUCTION OR LOSS OF DCC GENE-EXPRESSION IN HUMAN OSTEOSARCOMA
Authors: HORSTMANN MA POSL M SCHOLZ RB ANDEREGG B SIMON P BAUMGAERTL K DELLING G KABISCH H
Citation: Ma. Horstmann et al., FREQUENT REDUCTION OR LOSS OF DCC GENE-EXPRESSION IN HUMAN OSTEOSARCOMA, British Journal of Cancer, 75(9), 1997, pp. 1309-1317
ANTIMYCOTIC THERAPY WITH LIPOSOMAL AMPHOTERICIN-B FOR PATIENTS UNDERGOING BONE-MARROW OR PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION
Authors: KRUGER WH RUSSMANN BC KROGER N EKOPF N FUCHS N SOBOTTKA I ERTTMANN R KABISCH H ZANDER AR
Citation: Wh. Kruger et al., ANTIMYCOTIC THERAPY WITH LIPOSOMAL AMPHOTERICIN-B FOR PATIENTS UNDERGOING BONE-MARROW OR PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION, Blood, 90(10), 1997, pp. 4414-4414
SUCCESSFUL TREATMENT OF HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, HLH, WITHUNRELATED AND RELATED ALLOGENEIC BONE-MARROW TRANSPLANTATION
Authors: DURKEN M HORSTMANN M BIELING P KABISCH H ERTTMANN R LOLIGER C KRUGER W KROGER N JANKA G ZANDER A
Citation: M. Durken et al., SUCCESSFUL TREATMENT OF HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, HLH, WITHUNRELATED AND RELATED ALLOGENEIC BONE-MARROW TRANSPLANTATION, Blood, 90(10), 1997, pp. 4525-4525
EARLY TOXICITY OF INTENSIFIED CONDITIONING WITH ETOPOSIDE COMBINED WITH TOTAL-BODY IRRADIATION CYCLOPHOSPHAMIDE OR BUSULFAN CYCLOPHOSPHAMIDE IN CHILDREN UNDERGOING AUTOLOGOUS OR ALLOGENEIC BONE-MARROW TRANSPLANTATION
Authors: HORSTMANN M KROSCHKE G STOCKSCHLADER M BETKER R KRUGER W ERTTMANN R KABISCH H ZANDER A
Citation: M. Horstmann et al., EARLY TOXICITY OF INTENSIFIED CONDITIONING WITH ETOPOSIDE COMBINED WITH TOTAL-BODY IRRADIATION CYCLOPHOSPHAMIDE OR BUSULFAN CYCLOPHOSPHAMIDE IN CHILDREN UNDERGOING AUTOLOGOUS OR ALLOGENEIC BONE-MARROW TRANSPLANTATION, Pediatric hematology and oncology, 13(1), 1996, pp. 45-53
INCIDENCE AND CLINICAL OUTCOME OF CHILDREN WITH BCR ABL-POSITIVE ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) - A PROSPECTIVE RT-PCR STUDY BASED ON 673 PATIENTS ENROLLED IN THE GERMAN PEDIATRIC MULTICENTER THERAPY TRIALS ALL-BFM-90 AND COALL-05-92/
Authors: SCHLIEBEN S BORKHARDT A REINISCH I RITTERBACH J JANSSEN JWG RATEI R SCHRAPPE M REPP R ZIMMERMANN M KABISCH H JANKASCHAUB G BARTRAM CR LUDWIG WD RIEHM H LAMPERT F HARBOTT J
Citation: S. Schlieben et al., INCIDENCE AND CLINICAL OUTCOME OF CHILDREN WITH BCR ABL-POSITIVE ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) - A PROSPECTIVE RT-PCR STUDY BASED ON 673 PATIENTS ENROLLED IN THE GERMAN PEDIATRIC MULTICENTER THERAPY TRIALS ALL-BFM-90 AND COALL-05-92/, Leukemia, 10(6), 1996, pp. 957-963
INCREASE OF MOBILIZED CD34-POSITIVE PERIPHERAL-BLOOD PROGENITOR CELLSIN PATIENTS WITH HODGKINS-DISEASE, NON-HODGKINS-LYMPHOMA, AND CANCER OF THE TESTIS
Authors: ZELLER W GUTENSOHN K STOCKSCHLADER M DIERLAMM J KROGER N KOEHNE G HUMMEL K KABISCH H WEH HJ KUHNL P HOSSFELD DK ZANDER AR
Citation: W. Zeller et al., INCREASE OF MOBILIZED CD34-POSITIVE PERIPHERAL-BLOOD PROGENITOR CELLSIN PATIENTS WITH HODGKINS-DISEASE, NON-HODGKINS-LYMPHOMA, AND CANCER OF THE TESTIS, Bone marrow transplantation, 17(5), 1996, pp. 709-713
MLL ENL FUSION IN CONGENITAL ACUTE LYMPHOBLASTIC-LEUKEMIA WITH A UNIQUE T(11-18-19)/
Authors: HORSTMANN M ARGYRIOUTIRITA A BORKHARDT A KABISCH H KAPAUN P WINKLER K HAAS OA
Citation: M. Horstmann et al., MLL ENL FUSION IN CONGENITAL ACUTE LYMPHOBLASTIC-LEUKEMIA WITH A UNIQUE T(11-18-19)/, Cancer genetics and cytogenetics, 88(2), 1996, pp. 103-109
COMPARISON OF HEMATOLOGICAL RECOVERY KINETICS AFTER MYELOABLATIVE THERAPY BETWEEN SIBLING ALLOGENEIC BONE-MARROW AND PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION IN THE SAME ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA PATIENT
Authors: STOCKSCHLADER M HASSAN HT KRUGER W KABISCH H ZANDER A
Citation: M. Stockschlader et al., COMPARISON OF HEMATOLOGICAL RECOVERY KINETICS AFTER MYELOABLATIVE THERAPY BETWEEN SIBLING ALLOGENEIC BONE-MARROW AND PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION IN THE SAME ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA PATIENT, Leukemia research, 20(11-12), 1996, pp. 993-996
CYCLOPHOSPHAMIDE ANTITHYMOCYTE GLOBULIN CONDITIONING OF PATIENTS WITHSEVERE APLASTIC-ANEMIA FOR MARROW TRANSPLANTATION FROM HLA-MATCHED SIBLINGS - PRELIMINARY-RESULTS/
Authors: HORSTMANN M STOCKSCHLADER M KRUGER W HOFFKNECHT M BETKER R KABISCH H ZANDER A
Citation: M. Horstmann et al., CYCLOPHOSPHAMIDE ANTITHYMOCYTE GLOBULIN CONDITIONING OF PATIENTS WITHSEVERE APLASTIC-ANEMIA FOR MARROW TRANSPLANTATION FROM HLA-MATCHED SIBLINGS - PRELIMINARY-RESULTS/, Annals of hematology, 71(2), 1995, pp. 77-81
P53 MUTATION AND MDM2 SAS-AMPLIFICATION IN HUMAN OSTEOSARCOMA
Authors: SCHOLZ RB HORSTMANN M WITTENSTEIN B BALLI T WEBER B DELLING G KABISCH H WINKLER K
Citation: Rb. Scholz et al., P53 MUTATION AND MDM2 SAS-AMPLIFICATION IN HUMAN OSTEOSARCOMA, Journal of cellular biochemistry, 1995, pp. 76-76
DIFFERENT YIELDS OF G-CSF MOBILIZED CD34 POSITIVE PERIPHERAL-BLOOD PROGENITOR CELLS IN PATIENTS WITH CANCER OF THE TESTIS, NON-HODGKINS-LYMPHOMA AND HODGKINS-DISEASE
Authors: ZELLER W KRUGER W STOCKSCHLADER M GUTENSOHN K DIERLAMM J KABISCH H HOSSFELD DK ZANDER AR
Citation: W. Zeller et al., DIFFERENT YIELDS OF G-CSF MOBILIZED CD34 POSITIVE PERIPHERAL-BLOOD PROGENITOR CELLS IN PATIENTS WITH CANCER OF THE TESTIS, NON-HODGKINS-LYMPHOMA AND HODGKINS-DISEASE, Experimental hematology, 23(8), 1995, pp. 757-757
INCREASING THE YIELD OF HARVESTED BONE-MARROW CELLS BY RAISING ROOM-TEMPERATURE DURING MARROW COLLECTION
Authors: ZELLER W HESSE I DURKEN M STOCKSCHLADER M KRUGER W PETERS SO WALTER TA GREENSHAW C KABISCH H ZANDER AR
Citation: W. Zeller et al., INCREASING THE YIELD OF HARVESTED BONE-MARROW CELLS BY RAISING ROOM-TEMPERATURE DURING MARROW COLLECTION, Experimental hematology, 23(14), 1995, pp. 1527-1529
BONE-MARROW TRANSPLANTATION FOR PHILADELPHIA-CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC-LEUKEMIA
Authors: STOCKSCHLADER M HEGEWISCHBECKER S KRUGER W DIECK AT MROSS K HOFFKNECHT M BERGER C KOHLSCHUTTER B MARTIN H PETERS S KABISCH H KUSE R WEH H ZANDER A
Citation: M. Stockschlader et al., BONE-MARROW TRANSPLANTATION FOR PHILADELPHIA-CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC-LEUKEMIA, Bone marrow transplantation, 16(5), 1995, pp. 663-667
Risultati: 1-25 | 26-35